A mild phenoxysilyl linker for self-immolative release of antibody-drug conjugates

被引:4
|
作者
Wei, Ding [1 ,2 ,3 ]
Mao, Yurong [2 ,3 ]
Wang, Huihui [2 ,3 ]
Qu, Siqi [2 ,3 ]
Chen, Jiakang [2 ]
Li, Jiusheng [1 ]
Jiang, Biao [2 ]
Chen, Hongli [2 ]
机构
[1] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai 201210, Peoples R China
[2] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
关键词
Antibody-drug conjugates; Self-immolative release; Phenoxysilyl linker; Combretastatin A4 (CA4); DELIVERY; ACTIVATION; PAYLOADS; DESIGN;
D O I
10.1016/j.cclet.2022.108091
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Self-immolative linkers have been widely used to construct prodrugs to improve their efficacy and safety. In this study, we report the use of phenoxysilyl linker as a self-immolative unit to prepare antibody-drug conjugates (ADCs). Phenoxysily based ADC Ate-PPS-CA4 was prepared and its release was systematically investigated by mass spectrometry. Biological evaluation showed that Ate-PPS-CA4 displayed the ability to target delivery and self-immolative release the active payload CA4 on PD-L1 positive cells MDA-MB-231. As the same with its payload CA4, it could arrest the cell cycle to the G2/M phase and induced changes in cell morphology at the dose of its IC50. The development of this linker with novel drug release mechanisms will expand the methodology to construct ADCs, especially for non-internalizing ADCs by extracellular cleavage.(c) 2023 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody-Drug Conjugates
    Marvin, Christopher C.
    Hobson, Adrian D.
    Mcpherson, Michael
    Dunstan, Theresa A.
    Vargo, Thomas R.
    Hayes, Martin E.
    Fettis, Margaret M.
    Bischoff, Agnieszka
    Wang, Lu
    Wang, Lu
    Hernandez Jr, Axel
    Jia, Ying
    Oh, Jason Z.
    Tian, Yu
    BIOCONJUGATE CHEMISTRY, 2023, 34 (10) : 1835 - 1850
  • [2] Modulating Therapeutic Activity and Toxicity of Pyrrolobenzodiazepine Antibody-Drug Conjugates with Self-Immolative Disulfide Linkers
    Pillow, Thomas H.
    Schutten, Melissa
    Yu, Shang-Fan
    Ohri, Rachana
    Sadowsky, Jack
    Poon, Kirsten Achilles
    Solis, Willy
    Zhong, Fiona
    Del Rosario, Geoffrey
    Go, Mary Ann T.
    Lau, Jeffrey
    Yee, Sharon
    He, Jintang
    Liu, Luna
    Ng, Carl
    Xu, Keyang
    Leipold, Douglas D.
    Kamath, Amrita V.
    Zhang, Donglu
    Masterson, Luke
    Gregson, Stephen J.
    Howard, Philip W.
    Fang, Fan
    Chen, Jinhua
    Gunzner-Toste, Janet
    Kozak, Katherine K.
    Spencer, Susan
    Polakis, Paul
    Polson, Andrew G.
    Flygare, John A.
    Junutula, Jagath R.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) : 871 - 878
  • [3] Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment
    Edupuganti, Veera V. Shivaji R.
    Tyndall, Joel D. A.
    Gamble, Allan B.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2021, 16 (04) : 479 - 497
  • [4] The Methylene Alkoxy Carbamate Self-Immolative Unit: Utilization for the Targeted Delivery of Alcohol-Containing Payloads with Antibody-Drug Conjugates
    Kolakowski, Robert V.
    Haelsig, Karl T.
    Emmerton, Kim K.
    Leiske, Chris I.
    Miyamoto, Jamie B.
    Cochran, Julia H.
    Lyon, Robert P.
    Senter, Peter D.
    Jeffrey, Scott C.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (28) : 7948 - 7951
  • [5] Peptide-Cleavable Self-immolative Maytansinoid Antibody-Drug Conjugates Designed To Provide Improved Bystander Killing
    Costoplus, Juliet A.
    Veale, Karen H.
    Qiu, Qifeng
    Ponte, Jose F.
    Lanieri, Leanne
    Setiady, Yulius
    Dong, Ling
    Skaletskaya, Anna
    Bartle, Laura M.
    Salomon, Paulin
    Wu, Rui
    Maloney, Erin K.
    Kovtun, Yelena V.
    Ab, Olga
    Lai, Kate
    Chari, Ravi V. J.
    Widdison, Wayne C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (10): : 1393 - 1399
  • [6] Antibody-drug conjugates: Recent advances in linker chemistry
    Su, Zheng
    Xiao, Dian
    Xie, Fei
    Liu, Lianqi
    Wang, Yanming
    Fan, Shiyong
    Zhou, Xinbo
    Li, Song
    ACTA PHARMACEUTICA SINICA B, 2021, 11 (12) : 3889 - 3907
  • [7] Toward a Ferrous Iron-Cleavable Linker for Antibody-Drug Conjugates
    Spangler, Benjamin
    Kline, Toni
    Hanson, Jeffrey
    Li, Xiaofan
    Zhou, Sihong
    Wells, James A.
    Sato, Aaron K.
    Renslo, Adam R.
    MOLECULAR PHARMACEUTICS, 2018, 15 (05) : 2054 - 2059
  • [8] Antibody-drug conjugates: recent advances in conjugation and linker chemistries
    Tsuchikama, Kyoji
    An, Zhiqiang
    PROTEIN & CELL, 2018, 9 (01) : 33 - 46
  • [9] Hybrid Polyester Self-Immolative Polymer Nanoparticles for Controlled Drug Release
    Gambles, Michael T.
    Fan, Bo
    Borecki, Aneta
    Gillies, Elizabeth R.
    ACS OMEGA, 2018, 3 (05): : 5002 - 5011
  • [10] Investigation of Antibody-Drug Conjugates by Mass Spectrometry
    Jayathirtha, Madhuri
    Darie, Costel C.
    ADVANCEMENTS OF MASS SPECTROMETRY IN BIOMEDICAL RESEARCH, 2ND EDITION, 2019, 1140 : 251 - 263